| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harrow, Inc. (HROW) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. HROW is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.99M | $126.64M | - | |
| CFO | 837.8K | $35.53M | - | |
| 10% | 70.0K | $2.97M | - | |
| Other | 30.0K | $1.27M | - | |
| Other | 15.0K | $636.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $6.91 | $69,100.00 | -1.1% | |
| Feb 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.86 | $58,600.00 | -1.1% | |
| Jan 2, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.33 | $53,300.00 | -1.1% | |
| Dec 3, 2018 | Kammer Robert J | Director | Sell | 10,000 | $4.64 | $46,400.00 | -1.1% | |
| Nov 1, 2018 | Kammer Robert J | - | Sell | 10,000 | $4.21 | $42,100.00 | -1.1% | |
| Oct 15, 2018 | Kammer Robert J | Director | Sell | 10,000 | $3.00 | $30,000.00 | -1.1% | |
| Sep 4, 2018 | Kammer Robert J | - | Sell | 10,000 | $3.00 | $30,000.00 | -1.1% | |
| Aug 10, 2018 | Kammer Robert J | Director | Sell | 130,000 | $3.00 | $390,000.00 | -12.3% | |
| Jul 17, 2017 | Kammer Robert J | Director | Sell | 10,000 | $3.05 | $30,526.00 | -0.9% | |
| Dec 19, 2016 | Lindstrom Richard L Md65 | Director | Buy | 100,000 | $1.79 | $179,000.00 | New |